Eurizon Capital SGR S.p.A. »

Royalty Pharma shares owned by Eurizon Capital SGR S.p.A.

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Eurizon Capital SGR S.p.A. from 13F filings

Historical chart of Eurizon Capital SGR S.p.A. investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Eurizon Capital SGR S.p.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Eurizon Capital SGR S.p.A.

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 318k 47.81

More positions owned by Eurizon Capital SGR S.p.A.

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Bank of America Corporation (BAC)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Eurizon Capital SGR S.p.A.

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma